Literature DB >> 3208836

Muscarinic M1, M2 receptor binding. Relationship with functional efficacy.

S B Freedman1, M S Beer, E A Harley.   

Abstract

A comparison has been made between [3H]pirenzepine binding to the M1 receptor population of rat cerebral cortex and [3H]N-methylscopolamine binding to M2 receptors in rat cardiac membranes. Several standard muscarinic antagonists including trihexyphenidyl HCl, benztropine, biperidin and 4-DAMP (4-diphenylacetoxy-N-methyl piperidine methiodide) showed some selectivity for the M1 binding assay. Dicyclomine and hexahydrosiladifenidol were the only antagonists with a selectivity approaching that of pirenzepine. Gallamine and AFDX-116 were the only M2 (cardiac) selective antagonists. Muscarinic agonists displayed profiles which could be classified into two groups, apparently related to their intrinsic activity. One group displayed apparent selectivity for the heart, with low Hill coefficients and contained full agonists such as acetylcholine. The second group displayed less selectivity, intermediate Hill coefficients and contained partial agonists such as pilocarpine. Thus muscarinic agents can distinguish between different tissues not only on the basis of receptor selectivity, but also by recognition of high and low agonist affinity states. Thus the intrinsic activity of a muscarinic agonist may reflect an apparent but not true receptor-mediated selectivity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3208836     DOI: 10.1016/0014-2999(88)90155-0

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  6 in total

Review 1.  Remyelination Pharmacotherapy Investigations Highlight Diverse Mechanisms Underlying Multiple Sclerosis Progression.

Authors:  George S Melchor; Tahiyana Khan; Joan F Reger; Jeffrey K Huang
Journal:  ACS Pharmacol Transl Sci       Date:  2019-11-14

2.  Muscarinic receptor/G-protein coupling is reduced in the dorsomedial striatum of cognitively impaired aged rats.

Authors:  Erasmo Nieves-Martinez; Kathryn Haynes; Steven R Childers; William E Sonntag; Michelle M Nicolle
Journal:  Behav Brain Res       Date:  2011-11-07       Impact factor: 3.332

Review 3.  Remyelination therapies: a new direction and challenge in multiple sclerosis.

Authors:  Jason R Plemel; Wei-Qiao Liu; V Wee Yong
Journal:  Nat Rev Drug Discov       Date:  2017-07-07       Impact factor: 84.694

4.  Presynaptic effects of muscarine on ACh release at the frog neuromuscular junction.

Authors:  I Slutsky; H Parnas; I Parnas
Journal:  J Physiol       Date:  1999-02-01       Impact factor: 5.182

5.  Muscarinic acetylcholine response in pyramidal neurones of rat cerebral cortex.

Authors:  M Nishikawa; M Munakata; N Akaike
Journal:  Br J Pharmacol       Date:  1994-08       Impact factor: 8.739

6.  Selective attenuation of Ether-a-go-go related K+ currents by endogenous acetylcholine reduces spike-frequency adaptation and network correlation.

Authors:  Edward D Cui; Ben W Strowbridge
Journal:  Elife       Date:  2019-04-29       Impact factor: 8.140

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.